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Eung Kweon Kim1
PURPOSE. The effects of insulin-like growth factor (IGF)-1 on
laminin (Ln)-5 and the associated integrins during in vitro
HCEC migration were examined. Also investigated were the
effects of IGF-1 on the migration of human corneal epithelial
cells (HCECs).
METHODS. HCEC migration was examined by wound-healing
and chemoattraction assays. For migration inhibition assays,
HCECs were pretreated with inhibitors of the IGF-1 receptor
(IR3), the PI3-K/AKT pathway (LY294002), and the MEK-ERK
pathway (PD98059). The expression levels of Ln-5 and fi-
bronectin (Fn) were determined by Western blot analysis, and
the expression levels of the 1 and 3 integrins were deter-
mined by confocal microscopy and Western blot analysis. The
migration inhibition with anti-integrin 3 and 1 antibodies
was also determined.
RESULTS. HCEC migration was significantly increased in the
presence of IGF-1 and Ln-5. IGF-1 enhanced the production of
Ln-5 in both a dose- and time-dependent manner, and this
upregulation was blocked by pretreatment with IR3 or
LY294002. IGF-1 treatment upregulated expression of 1 inte-
grin, but not 3 integrin. The HCEC migration facilitated by
IGF-1 was inhibited with the anti-integrin antibody for 1.
However, there was no cross-talk between Ln-5 and integrin 1
production.
CONCLUSIONS. The results reveal that IGF-1 induces HCEC mi-
gration through the independent production of Ln-5 and 1
integrin, which are directed at least in part by activation of the
PI3-K/AKT pathway, but are not affected by the MEK-ERK
pathway. (Invest Ophthalmol Vis Sci. 2006;47:873–882) DOI:
10.1167/iovs.05-0826
The corneal epithelium is a self-renewing, stratified epithe-lium that provides the first line of defense against invading
microorganisms. The integrity of the corneal surface depends
on a delicate balance among the forces of corneal epithelial cell
proliferation, migration, differentiation, and desquamation.1
Disruption of the corneal epithelial barrier activates the cor-
neal healing and remodeling processes, which can predispose
the tissue to stromal ulceration and cause corneal opacifica-
tion, ultimately leading to irreversible visual deficits. Epithelial
healing is achieved by migration of the epithelial cells to cover
the denuded area and enhanced cell proliferation to reestablish
the epithelial structure. Corneal epithelial cell migration is
modulated by various humoral and extracellular matrix (ECM)
proteins.1 Growth factors, such as insulin-like growth factor
(IGF)-1,2 epidermal growth factor (EGF),3 interleukin 6,4 fibro-
blast growth factor-2 (FGF-2),5 transforming growth factor-
(TGF-),6 keratinocyte growth factor (KGF), and hepatocyte
growth factor (HGF)7,8 have been shown to stimulate corneal
epithelial cell migration both in vivo and in vitro. Glycopro-
teins of the ECM, such as fibronectin (Fn), laminin (Ln), and
collagen IV, also facilitate cell migration.9,10 However, the
precise relationship between these motogenic cytokines and
ECM protein production in the corneal epithelium is not well
understood.
The Ln proteins are a family of ECM molecules that exist as
cross-shaped heterotrimers of the -, - and -chains and are
mainly localized in the basement membranes of various tissues.
The five -, three -, and three -chains give rise to at least 15
Ln isoforms.11 Of them, Ln-1 and -5 are known to be compo-
nents of the corneal basement membrane. Ln-1 is the universal
isoform of Ln and comprises almost all the tissues in the
basement membrane,11 whereas Ln-5, which is composed of
the 3-, 3-, and 2-chains, is a component of skin and corneal
basement membranes and is known to be involved in epithelial
cell migration and adhesion.12,13 Genetic defects in any of the
three Ln-5 subunits cause junctional epidermolysis bullosa,14
and Ln-5 has been shown to be overexpressed at the sites of
epithelial wounds15 and the leading edges of invading carci-
noma cells.16 Taken together, these findings suggest that Ln-5
may play an important role in epithelial cell homeostasis, cell
migration, and cancer cell invasion.
IGF-1 is a multifunctional regulatory peptide that shares
structural homology with proinsulin. It has been shown to
mediate proliferation, differentiation, and survival effects, de-
pending on the target cell and the presence of other hormones
and growth factors.17 Accumulating evidence indicates that
IGF-1 promotes cell motility in a variety of normal and malig-
nant cell types, including the corneal epithelial cells of some
species. Nishida et al.18 reported that substance P and IGF-1
synergistically stimulated corneal epithelial migration in an
organ culture of the cornea, and found that although addition
of SP or IGF-1 alone did not affect epithelial migration, cotreat-
ment with SP and IGF-1 significantly stimulated it.19 Of note,
no previous work has examined the migratory effects of IGF-1
in primary human corneal epithelial cells (HCECs), or the
possibility of cross-talk between ECM components and migra-
tion-associated cytokines in this context.
In the current study, we investigated whether IGF-1 stimu-
lates HCEC migration and whether the expression levels of
Ln-5 and/or the Ln-5-associated integrins are altered during
IGF-1-induced HCEC migration in vitro.
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MATERIALS AND METHODS
Reagents
Human recombinant Ln-5, which consists of the 160-kDa 3-chain, the
135-kDa 3-chain, and the 150- and 105-kDa forms of the 2-chain, was
purified as previously described.20 The monoclonal human Ln-5 anti-
body (P3H9–2) was purchased from Chemicon (Temecula, CA), poly-
clonal Ln-3 (H-300) and -2 (H-183) from Santa Cruz Biotechnology,
Inc. (Santa Cruz, CA), and human Fn and type IV collagen from
Sigma-Aldrich Chemical Co. (St. Louis, MO). The monoclonal anti-3
integrin antibody (Gi9) was purchased from Beckman Coulter (Fuller-
ton, CA) and monoclonal anti-integrin 1 (CD29; clone JB1A) from
Chemicon. Anti-phospho-AKT (Ser473) and anti-phospho-ERK
(Thr980) antibodies were purchased from Cell Signaling Technology
(Beverly, MA). Anti-phospho-JNK (SAPK; Thr183/Tyr185) and anti-
human p38/SAPK2, a monoclonal antibody (clone 2F11) were pur-
chased from Biosource International (Camarillo, CA). Neutralizing hu-
man anti-IGF-1R mAb IR3 antibodies were obtained from Oncogene
Research Products (San Diego, CA). Dulbecco’s modified Eagle’s me-
dium (DMEM), Ham’s F-12 nutrient mixture, fetal bovine serum (FBS),
HEPES-buffer, amphotericin B, and gentamicin were purchased from
Invitrogen-Gibco (Grand Island, NY). Other reagents and chemicals,
including mouse-derived epidermal growth factor (EGF), cholera toxin
(subunit A), dimethyl sulfoxide (DMSO), hydrocortisone, transferrin,
and human insulin were purchased from Sigma-Aldrich. Dispase II was
purchased from Roche Applied Science (Mannheim, Germany). Affin-
ity-purified goat polyclonal antibodies against human IGF-1 and IGF-1
receptor (IGF-1R) were purchased from R&D Systems, Inc. (Minneap-
olis, MN). Horseradish peroxidase–conjugated secondary antibodies
were purchased from Dako (Glostrup, Denmark), and LY294002 and
PD98059 were purchased from Calbiochem (Darmstadt, Germany).
Preparation of Human Corneal Limbal Tissue for
Primary Epithelial Cell Culture
In accordance with the tenets of the Declaration of Helsinki and with
the permission of the institutional review board, human corneal limbal
tissue was harvested from donor corneal buttons after keratoplasty.
The corneal limbal tissues were washed three times with DMEM
containing 50 g/mL gentamicin and 1.25 g/mL amphotericin B. After
removal of excessive conjunctiva, sclera, and iris tissues, the remaining
tissue samples were placed in culture dishes and exposed for 1 hour to
1.2 U/mL dispase II in a Mg2- and Ca2-free solution at 37°C under
95% humidity and 5% CO2. In each case, the epithelial tissue was
separated from the rest of the tissue and cut into 2.0-mm2 tissue
sections with a no. 15 blade and scissors. The segmented epithelial
tissue was placed on the upper chamber of a cell migration apparatus
(Transwell; diameter, 6.5 mm; pore size, 0.4 m, Corning-Costar,
Acton, MA) containing 3T3 fibroblasts in the lower chamber, and cells
were cultured in supplemented hormonal epithelial medium (SHEM)
made of an equal volume of HEPES-buffered DMEM containing bicar-
bonate and Ham’s F-12 medium supplemented with 10% FBS, 0.5%
DMSO, 50 g/mL gentamicin, 1.25 g/mL amphotericin B, 2 ng/mL
mouse EGF, 5 g/mL insulin, 5 g/mL transferrin, 0.5 mg/mL hydro-
cortisone, and 30 ng/mL cholera toxin. Human corneal limbal epithe-
lial cells were maintained at 37°C under 95% humidity and 5% CO2.
The medium was changed every other day, and cell outgrowth was
monitored daily for 3 weeks by inverted phase microscopy (model
IX70; Olympus, Tokyo, Japan). When the cultured corneal epithelium
was 80% to 90% confluent, the cells were subcultured with 0.25%
trypsin and 5.0 mM EDTA with a 1:3 split. Second- and third-passage
cells were used for all experiments involving cultured human corneal
epithelium.
Migration Assay
HCEC migration was determined by monolayer wound-healing and
chemoattraction assays. During these experiments, we omitted both
serum and growth factors for 12 hours from the SHEM to mitigate the
effect of migration-related cytokines. All the experiments were per-
formed three times in a minimum of three samples, and at least three
different areas were observed in each sample.
For monolayer scratch assays, 2  106 cells were plated onto a
chamber slide and incubated in SHEM. When a confluent monolayer
was formed, cells were incubated in serum- and growth factor-free
SHEM medium for 12 hours. Then, a scratch wound was made with a
fire-polished glass pipette, and the cells were further incubated in the
presence or absence of various concentrations of IGF-1, Ln-5, type IV
collagen, and Fn. Migration was examined at various time points up to
48 hours. The plates were washed three times with PBS, and the
migratory cells were counted and photographed with a microscope
(model IX70; 50 and 100 magnifications; Olympus, Tokyo, Japan,).
The chemotaxis assays were performed with a modified Boyden
chamber assay. Briefly, cell-migration chambers (six-well plate, Trans-
well; Corning-Costar) were used, containing 6.5-mm, 8.0-m pore size
polycarbonate membrane inserts that were coated with 500 ng/mL
human type IV collagen, Fn, or various concentrations of recombinant
Ln-5 (10, 50, 100, or 1000 ng/mL) in PBS for 2 hours at 37°C. Then, the
inserters were rinsed twice with PBS and blocked with 1% heat-
inactivated BSA in PBS for 60 minutes at room temperature. The upper
chamber was loaded with HCECs at 1000 L of 2  106cells/mL, and
the apparatus was incubated for 24 hours. Before counting the migra-
tory cells on the lower surface of the inserter, the lower surface of the
membrane was washed twice with PBS, fixed with 4% paraformalde-
hyde with PBS for 15 minutes, and stained with 0.1% crystal violet for
15 minutes. The migratory cells were quantified by counting three
fields of view (100) with the same microscope used in the monolayer
scratch assay. Experiments were performed in triplicate and repeated
at least twice.
Migratory Function Blocking Study
For inhibitory studies, cells were incubated for 2 hours with one of the
following: 25 or 50 M of LY294002 inhibitor of phosphoinositide-3
kinase (PI3-K)/AKT) and PD98059 (inhibitor of ERK), blocking or
neutralizing antibodies against IGF-1 receptor (IR3, 10 g/mL), 1
integrin (10 g/mL), 3 integrin (10 g/mL), or an IgG matched
control mAb, and migratory assays were performed as just described.
Western Blot Analysis
Cells were washed with ice-cold PBS and then lysed with cell lysis
buffer (20 mM HEPES [pH 7.2], 10% glycerol, 10 mM Na3VO4, 50 mM
NaF, 1 mM phenylmethylsulfonyl fluoride, 0.1 mM dithiothreitol, 1
g/mL leupeptin, 1 g/mL pepstatin, and 1% Triton X-100) on ice for
30 minutes. Lysates were sonicated, and the cell homogenates were
centrifuged at 15,000g for 10 minutes. The protein concentrations in
the resultant supernatants were determined with the Bradford reagent,
and equal amounts of protein (30 g) were boiled in Laemmli sample
buffer and resolved by 8% SDS-PAGE. The proteins were transferred to
polyvinylidene fluoride (PVDF) membranes (Immobilon; Millipore, Bil-
lerica, MA) and probed overnight with antibodies against Fn; Ln 3-,
-3-, and -2-chains; and integrins 3 and -1 (diluted 1:500–1:3000).
The immunoreactive bands were detected with horseradish peroxida-
se–conjugated secondary antibodies and visualized by enhanced
chemiluminescence.
Immunocytochemical Staining
Cells were fixed for 5 minutes in 3.7% formaldehyde and then perme-
abilized in 0.5% Triton X-100 for 8 minutes. Single- or double-label
immunofluorescence was performed. In control experiments, samples
were run without primary antibodies or with irrelevant IgG to deter-
mine nonspecific binding of secondary antibodies. For the experi-
ments, the samples were incubated with anti-integrin 3, -integrin 1,
and -Ln-5 for 2 hours at room temperature, followed by incubation for
1 hour with FITC-conjugated secondary antibodies. The samples were
then rinsed with PBS and observed under a fluorescence microscope
(Eclipse TE200 equipped with a digital camera DXM 1200; Nikon,
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Tokyo, Japan) using appropriate filters for visualization of the fluores-
cein.
Statistics
All data are expressed as the mean  SD. Multivariate analysis of
variance with post hoc Newman-Keuls tests determined significant
differences between the treatment groups. P  0.05 was considered
statistically significant.
RESULTS
Effect of IGF-1 on HCEC Migration
HCEC monolayers were wounded, and migration was as-
sessed after treatment with various concentrations of IGF-1.
Twelve hours after wounding, serum- and growth factor–
free control cells demonstrated minimal movement into the
denuded area. In contrast, cells treated with 10 and 50
ng/mL IGF-1 substantially migrated into the denuded area
and showed a dose-dependent relationship with the concen-
tration of applied IGF-1 (Figs. 1A, B) Migrating cells were
flattened, with ruffling borders and lamellipodia (Fig. 1A).
These morphologic changes were more clearly obvious in
IGF-1-treated cells than in control cells. These results indi-
cate that IGF-1 treatment dose dependently increases migra-
tion of HCECs.
Effect of IGF-1 on PI3-K and MAPK Signaling
in HCECs
To examine IGF-1 signaling in human corneal epithelial cells,
serum- and growth factor-starved cells were treated with 10
ng/mL IGF-1 for up to 3 hours and analyzed for activation of the
PI3-K/AKT and mitogen-activated protein kinase (MAPK) path-
ways (Fig. 2). Phosphorylation of AKT was detectable within 5
minutes and persisted for at least 180 minutes after IGF-1
treatment, whereas phosphorylation of ERK1/2 was increased
at 10 minutes and remained above basal level for at least 180
minutes. In contrast, there was no evidence of activating phos-
phorylation of JNK or p38. These data suggest that in HCECs,
IGF-1 induces activation of PI3-K/AKT and ERK 1/2, but not
JNK or p38.
Effect of Inhibition of IGF-1 Signaling
Components on IGF-1-Induced HCEC Migration
Because our results revealed that PI3-K and ERK 1/2 were
involved in IGF-1-mediated intracellular signaling in HCECs,
and a previous study had shown that 3 and 1 integrins
FIGURE 1. Cell restitution assay of
the effect of IGF-1 on migration of
HCECs. Monolayers were scratched
and treated with or without 10 or 50
ng/mL IGF-1. Twelve hours later, the
plates were washed three times with
phosphate buffered saline (PBS), and
the migratory cells were counted and
photographed with an inverted mi-
croscope. (A, B) *Significant differ-
ence (P  0.05; one-way ANOVA).
Bars, SE.
FIGURE 2. Western blot analysis of phospho-AKT, -ERK 1/2, -JNK, and
-p38 in HCECs treated with IGF-1 (10 ng/mL). Serum- and growth
factor–starved HCECs were treated with IGF-1 for the indicated times,
and cell lysates (30 g) were resolved by 8% SDS-PAGE and immuno-
blotted with anti-pAKT, -pERK1/2, -phospho-JNK, and -phospho-p38
antibodies. -Actin served as the loading control.
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mediate epithelial cell migration in other cell types,21 we next
investigated the role of these factors in IGF-1-induced cell
migration. Wound-healing assays were conducted as described
earlier for 12 hours, and cell migration was compared between
cells treated with IGF-1 (10 ng/mL) alone and those pretreated
with neutralizing antibodies and chemical inhibitors. As shown
in Figure 3, LY294002 (25 M) and anti-1 integrin antibodies
(10 g/mL) completely blocked the IGF-1-induced HCEC mi-
gration, whereas an ERK inhibitor (PD98059; 25 M) and the
anti-3 integrin antibodies (10 g/mL) did not. These data
confirm that PI3-K and 1 integrins are associated with IGF-1-
related HCEC migration.
Effect of IGF-1 Treatment on Ln-5
Subchain Expression
As Ln-5 and Fn are known to be important modulators of
HCEC migration,1,10 we next used Western blot analysis to
investigate the expression of Ln-5 and Fn after IGF-1 treat-
ment of HCECs. Ln-5 2 subchain production was increased
at 6 hours after treatment of IGF-1 (10 ng/mL), but no
change in Fn production was seen after IGF-1 treatment (Fig.
4A). Treatment with the ERK inhibitor (PD98059) had no
effect on the IGF-1-induced production of the 2 subchain,
whereas the specific PI3-K inhibitor (LY294002) decreased
the expression of the Ln-5 2 subchain (Fig. 4B).
To determine the expression of Ln-5 within a time se-
quence, immunoblot analysis for Ln-5 was performed after
IGF-1 treatment. In this experiment, some cells were pre-
treated with 25 and 50 M LY294002, 2 hours before IGF-1
treatment. The expression levels of the Ln-5 3-, 3-, and
2-subchains were significantly upregulated within 3 hours
after treatment, compared with the serum- and growth factor-
free control cultures (Fig. 4C). Both the processed (160 kDa)
and unprocessed (190 kDa) forms of the 3 subchain were
increased at 3 hours, but these levels had returned to control
levels at 6 and 12 hours. The expression levels of the 3 (155
kDa) and 2 (150 kDa: unprocessed, 105 kDa: processed)
subchains were significantly increased at 3 and 6 hours after
IGF-1 treatment and had returned to basal levels by 12 hours
after treatment. The 2 subchain expression levels peaked at 6
hours after treatment and showed the largest IGF-1-induced
change. Pretreatment of LY294002 blocked IGF-1-mediated
production of the 3- and 2-subchains in a dose-dependent
manner (Fig. 4C, lanes 3, 4).
Localization of Ln-5 during IGF-1-Induced
HCEC Migration
As the translocation of Ln-5 has been associated with cell
migration or attachment,13,16 indirect fluorescein micros-
copy was used to examine the localization patterns of Ln-5
during a monolayer scratch assay with 10 ng/mL IGF-1
treatment of HCECs. In serum-starved control cells, fewer
migratory cells were noted, and Ln-5 was not exactly local-
ized (Fig. 5A). Three hours after IGF-1 treatment, significant
Ln-5 expression was observed in the migratory leading cells
(Fig. 5B, arrows), compared with the trailing cells (Fig. 5B,
arrowheads). Time course analysis revealed that in IGF-1-
treated cells, Ln-5 expression progressively formed contin-
uous immunoreactive lines along the borders of migratory
cells (Figs. 5B, 5C). In cells pretreated with LY294002 be-
fore IGF-1 treatment, Ln-5 expression did not form contin-
uous lines along the borders of cells (Fig. 5D). In sharp
contrast, Ln-5 was also expressed within the marginal mem-
brane protrusions of cells treated with IGF-1 (Fig. 5E).
FIGURE 3. HCEC were pretreated with neutralizing antibodies against
the IR3 IGF-1 receptor (10 g/mL) and integrin 1 (10 g/mL) and 3
(10 g/mL), as well as inhibitors against PI3 kinase (LY294002; 25 M)
and ERK (PD98059; 25 M). The cells were then treated with IGF-1 (10
ng/mL) and migration was assessed in a wound-healing assay at 12
hours by microscope. *Significant (P  0.05; one-way ANOVA) inhibi-
tion compared with IGF-1 treatment alone. Bars, SE. Magnification,
50.
FIGURE 4. IGF-1-induced Ln-5 expression was determined by West-
ern immunoblot. Serum- and growth factor-starved cells were
treated with IGF-1 (10 ng/mL) and incubated for 6 hours. Cell
lysates were examined for production of Ln-5 subchain-2 and Fn by
Western blot analysis (A, B). Two hours before the IGF-1 treatment,
some cells were pretreated with a neutralizing antibody against the
IR3 IGF-1 receptor, or inhibitors LY294002 (25 M) and PD98059
(25 M). Ln-5 expression was compared over time. Lane 1: serum
and growth factor free; lane 2: 10 ng/mL IGF-1 treatment; lane 3: 10
ng/mL IGF-125 M LY294002; and lane 4: 10 ng/mL IGF-150
M LY294002 (C).
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HCEC Migration on Matrix Glycoproteins, Fn,
Ln-5, and Type IV Collagen
As our results suggested that IGF-1 can induce HCEC migration
and upregulation of Ln-5, we next investigated the effects of
Ln-5 on human corneal epithelial cells in early epithelial wound
healing. To compare the role of Ln-5 in cell migration with that
of other basement membrane glycoproteins, including Fn and
type IV collagen, cell migration was determined by chemoat-
traction assays on glycoprotein-precoated chamber slide in-
serts. As shown in Figure 6, HCEC migration increased on all
the tested matrix glycoproteins over 24 hours, compared with
the serum- and growth factor-free control cultures. The Ln-5-
coated inserts showed the highest levels of cell migration.
These levels began to show a statistically significant difference
from 6 hours after treatment, compared with the type IV
collagen- and Fn-coated slides, which showed increased cell
migration up to 24 hours after treatment.
To confirm these findings, another migration assay was
performed with a monolayer scratch injury, using cells incu-
bated in medium containing the various basement membrane
glycoproteins. The wounded monolayers were treated with or
without 500 ng/mL type IV collagen, Fn, or Ln-5, and migration
was observed. At 12 hours after assay, the Ln-5-treated HCEC
monolayer condition showed the highest levels of migration
compared with Fn- or type IV collagen–treated cells (Fig. 6B).
Next, the dose–response effect of Ln-5 on HCEC migration
was examined in additional chemoattraction assays. HCEC mi-
gration was not induced by Ln-5 concentrations below 100
ng/mL, whereas Ln-5 concentrations between 100 and 1000
ng/mL induced a significant increase in HCEC migration (Fig.
7A). With the time sequence, from 6 hours after the assay,
HCEC migration was facilitated by Ln-5, compared with the
control (Fig. 7B).
Effect of IGF-1 Treatment on Expression of 1
Integrin and 3 Integrin
In mammary epithelial cells, motility and adhesive interactions
with the matrix may be mediated by integrin expression lev-
els.22 Thus, we tested whether IGF-1-treated HCECs showed
changes in the expression levels of 3 and 1 integrins, which
are known to be related to Ln-5-associated cell migration.21
Western blot analysis revealed that 1 integrin expression was
increased at 6 and 12 hours after cells were treated with IGF-1,
and that this increase could be blocked by pretreatment with
LY294002 (Fig. 8).
FIGURE 5. Localization of laminin-5
in HCECs in the absence or presence
of IGF-1. An indirect immunofluores-
cence method was used to examine
Ln-5 localization in serum- and
growth factor–free control cells (A),
as well as those treated with 10
ng/mL IGF-1 for 3 (B) and 6 (C)
hours, and those pretreated with 25
M LY294002 for 2 hours before
treatment with IGF-1 (D). Arrows:
cytoplasmic processes and localiza-
tion of laminin-5 (arrowheads) in mi-
grating cells 3 hours after treatment
with IGF-1 (E).
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Effect of Neutralizing Anti-IGF-1 and Anti-integrin
Antibodies on HCEC Migration
To determine the relationships among Ln-5, integrin 3, and
integrin 1, HCEC migration on Ln-5 was examined in the
presence of anti-3 and -1 antibodies. As shown in Figure
9A, at 12 hours, the anti-integrin 1 neutralizing antibodies
significantly and dose dependently decreased cell migration
on Ln-5, whereas the anti-integrin 3 antibodies had a less-
pronounced inhibitory effect. Compared with the untreated
control, cell migration was inhibited by 45% in cultures
treated with 20 g/mL anti-integrin 1, but only by 11% in
cultures treated with 20 g/mL anti-integrin 3. These in-
hibitory effects continued for 48 hours (Fig. 9B). Treatment
with neutralizing antibodies against both 3 and 1 had an
inhibitory effect on cell migration similar to that in cells
treated with the anti-1 antibody alone (Fig. 9).
As these data indicate that the functional upregulation of
both Ln-5 and integrin 1 were essential for IGF-1-induced
HCEC migration, we investigated the production of integrin 1
in HCECs grown on Ln-5-coated matrices, to determine
whether cross-talk exists between Ln-5 and integrin 1. The
IGF-1-induced production of integrin 3 or 1 was similar in
the presence or absence of Ln-5 (Fig. 10), indicating no evi-
dence of cross-talk.
FIGURE 7. HCEC migration on Ln-5-coated inserts of a cell-migration
chamber over different doses (A) and time points (B). () Without
Ln-5; (u) with Ln-5 (100 ng/mL). *Significant difference (P  0.05;
one-way ANOVA) compared with serum- and growth factor–free con-
trols.
FIGURE 6. Comparison of HCEC migration on inserts coated with colla-
gen type 4 IV (E; 0.5 g/mL), Fn (; 0.5 g/mL), or Ln-5- (ƒ; 0.5 g/mL),
and serum- and growth factor-free controls (F). HCEC migration was
determined with chemoattractant assays for 24 hours (A). Wound-healing
experiments were conducted with or without 500 ng/mL of type IV
collagen, Fn, or Ln-5, and migratory cells were counted 12 hours after
injury (B). *Significant difference (P  0.05; one-way ANOVA) compared
with cells treated with 0.5 g/mL Fn. Bars, SE.
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DISCUSSION
The present study demonstrates that IGF-1 treatment of HCECs
can induce the expression of the matrix protein Ln-5 and its
cell surface receptor integrin 1, and that these effects are
associated with increased HCEC migration. The induction of
Ln-5 and integrin 1 by IGF-1 was inhibited by LY294002,
indicating the involvement of PI3-K/AKT signaling in this re-
sponse.
IGF-1 is a multifunctional peptide capable of promoting
migration in a wide range of normal and tumor cell types,23
including corneal epithelial cells. Although IGF-1 expression
has not yet been shown in the cornel epithelium in vivo,
expression of IGF-1R has been found in corneal epithelial cells
in vivo.24 Furthermore, we identified IGF-1 receptor expres-
sion in HCECs from a paraffin-embedded human corneal tissue
block, particularly in the limbal area, and noted IGF-1 produc-
tion in cultured HCECs (data not shown). These results suggest
that IGF-1 may be a key cytokine involved in processes central
to maintenance of the corneal epithelial surface (i.e., migration
and attachment). Recently, Shanley et al.25 reported that insu-
lin, a peptide that is closely related to IGF-1 and shares similar
mechanisms of signal transduction, promotes HCEC migration
through PI3 kinase signaling. PI3 kinase is an essential mole-
cule in IGF-1-induced cell migration and has anti-apoptosis
signaling functions in various cell types, including corneal
epithelial cells.26 IGF-1 is also known to promote corneal
epithelial cell (CEC) migration via substance P (SP).18,19 How-
ever, the migratory effect of IGF-1 is thought to be species- and
cell type–specific. Several studies have reported that IGF-1
stimulated the migration of CECs with a synergistic effect of SP
in rabbit2,18,27 and rat models.27,28 However, Murphy et al.29
reported that in dogs with spontaneous chronic corneal epi-
thelial defects, IGF-1 did not play a critical role in corneal
wound healing. Furthermore, McDermott et al.30 reported that
topical application of SP and/or IGF-1 did not modulate corneal
epithelial wound healing in galactosemic rats. However, few
prior studies have examined corneal epithelial cell migration in
primary human cells. In this study, it was demonstrated that
IGF-1 has a migratory effect on HCECs, and that this effect
involves signaling via the PI3 kinase pathway, but not the ERK,
JNK, or p38 pathways.
Cell migration to cover the defective area is one of the
most important events in wound repair. Although many
signaling pathways related to cell migration have been iden-
tified, the induction of signals that allow cells to migrate is
not well understood. Also, the pathways are different for
each cytokine or in each cell type. Andre et al.31 reported
that in a wound-healing assay, IGF-1-induced colonic epithe-
lial cell migration occurred through multiple signaling path-
ways, including PI3-K, MAP kinase, and protein kinase C
(PKC)- and -. However, in MCK-7 cells, the PI3-K pathway
was important for cellular motility, but the MAP kinase
pathway was not.32 The function of MAP kinase was found
to be essential for the motile response to MDCK canine
epithelial cells,33 whereas pretreatment with the MEK1 in-
hibitor, PD98059, was essential for the chemotactic re-
sponse of MCF-7 cells to IGF-1.34 Moreover, IGF-1-induced
migration has been associated with focal adhesion kinase
FIGURE 9. Effect of neutralizing antibodies against integrin 3 (E) and
1() on HCEC migration on 100 ng/mL Ln-5. HCECs were cultured
with or without 10 g/mL anti-3- and -1-antibodies for 48 hours in
the Ln-5-coated cell migration chamber. The results were compared in
terms of antibody concentration at 12 hours (A) and over time (B). (E)
Anti-integrin 3 alone; () anti-integrin 1 alone; (ƒ) both together;
and (F) control. *Significant (P  0.05; one-way ANOVA) difference
compared with the control.
FIGURE 8. The expression levels of integrin 3 and 1 in IGF-1-treated
HCECs. Cells were pretreated with LY294002 or left untreated for 2
hours, then treated with or without IGF-1 for up to 12 hours. HCEC
lysates were subjected to Western blot analysis with anti-integrin 3
and 1 antibodies. Lane 1: serum- and growth factor–free control; lane
2: IGF-1 10 ng/mL; lane 3: 25 M LY294002 pretreatment; and lane 4:
50 M LY294002 pretreatment.
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(FAK), PKC, c-Src, and integrins and was also shown to be
cross-regulated by ECM- and integrin-related signals, includ-
ing paxillin and p130CAS.35–37 In CEC wound healing, Saika
et al.6 reported that TGF- enhances CEC migration through
the activation of p38MAPK in C57BL/6J mice. And Sharma et
al.7 and Wilson et al.8 reported that cross-talk between p38
and ERK1/2 activation is essential in KGF- and HGF-induced
CEC migration. Taken together, our findings and those in the
previous reports indicate that activation of intracellular sig-
nal pathways for cell migration differs among various cell
types and species, and that these differences may be respon-
sible for the variations in activation of intracellular signal
pathways.
The cells of the basement membrane lay down matrix
and influence cellular activities such as adhesion, motility,
cytoskeletal organization, and gene expression.38 Ln-5, as a
component of the basement membrane, facilitates epithelial
cell migration and wound healing, and its expression may be
related to the spreading of corneal epithelial cells.39,40 Pre-
vious studies have reported that some tumor cell lines over-
express Ln-5 via migration-associated cytokines such as TGF-
41 and IL-6.42 However, this is the first study to report
the induction of Ln-5 by a cytokine in HCECs. Although Ln-5
was expressed in migrating HCECs in the absence of
IGF-1 treatment, addition of IGF-1 triggered further upregu-
lation of Ln-5. Western blot analysis revealed that although
IGF-1 treatment induced all three components of Ln-5 in
HCECs, the 3- and 2-chains were more prominently in-
creased than the 3-subchain, which is generally believed to
induce hemidesmosome assembly and cell attachment
through integrin interactions. In contrast, the 2-subchain
has been shown to be a central factor in cell migration.43
Thus, the stronger upregulation of the 2-subchain is con-
sistent with the effect of IGF-1 on migration, rather than
adhesion.
A single matrix molecule may demonstrate opposite ef-
fects on cell migration and adhesion when it adheres to
different integrins, due to differing effects on matrix protein
processing and assembly.1,11,43,44 For example, the matrix
molecule Ln-5 supports cell migration and is enriched at the
front of migrating cells, where it indirectly associates with
the reorganization of the actin cytoskeleton.44 However,
Ln-5 also plays an essential role in attachment of human
corneal epithelial cells.40 The mechanisms by which Ln-5
exerts two apparently opposite activities are poorly under-
stood. Some studies have suggested that stable adhesion is
mediated by interactions between Ln-5 and integrin
64,45,46 whereas cell migration is supported by interac-
tions between Ln-5 and integrin 31.35,47 the 31 inte-
grin has been reported to form complexes with the trans-
membrane-4 superfamily (TM4SF) proteins. These different
complexes have been suggested to play different roles in
various cell types.48,49 Tsuji et al.50 reported that A431
epidermoid cells produce a factor that potentiates the mo-
tility of melanoma cells in a 31-integrin-dependent man-
ner. Also, recent studies have shown that interactions be-
tween Ln-5 and integrin 71 or integrin 21 may be
involved in epithelial cell migration.51,52 Furthermore, Tai et
al.53 reported that IGF-1-induced cell migration is mediated
by 1 integrin activation and PI3-K/AKT signaling. In the
present study, we found that 1 integrin was also an impor-
tant migration-associated factor in HCECs, but 3 integrin
was not, and the 1 integrin was also induced by PI3-K, as
was Ln-5.
There is significant evidence of cross-talk between IGF-
1-associated PI3 kinase and ECM proteins in several cell
types. Nguyen et al.54 reported that deposition of Ln-5 and
ligation by integrin activated PI3 kinase signaling promoted
cell adhesion and spreading. Gu et al.55 reported that Fn and
some Ln isoforms could modulate PI3 kinase/Akt activity by
altering integrin expression. Our results did not provide
evidence of cross-talk between Ln-5 and 1 integrin, but it
remains possible that the induced Ln-5 proteins affect PI3-
K/AKT signaling via the cross-regulated integrin-dependent
signaling pathways in HCECs. Also, although Ln-5 did not
affect the production of 1 integrin, 1 integrin may be
activated by cross-linking with Ln-5 during HCEC migration.
In summary, we show for the first time that IGF-1 induces
HCEC migration by upregulation of Ln-5 and 1 integrin pro-
tein expression via the PI3-K/AKT pathway, but not the MEK-
ERK pathway. The inductions of Ln-5 and 1 integrin by IGF-1
appeared to occur independently, and most likely contributed
to IGF-1-induced cell migration. Future work is needed to
understand better the IGF-1-induced cytokine signaling within
the matrix.
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